Another is to find stocks with relatively affordable price tags per share. Although it's sometimes the case that the most ...

Sustainable health cannot be solved by science, clinical trial representation and access alone. It’s also down to how we live ...

Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduce ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

As the sector’s liabilities are high, 0.3 percent increment of the health budget won’t be enough to meet Sustainable ...

Dr. M.S. Reddy has been granted a groundbreaking United States patent (US Patent #12,268,717 B1) on April 8, 2025.

The Global Home Healthcare Services Market will witness a CAGR of 9-10% by 2029. The key factors driving the home healthcare ...

Scientists discovered a new way to protect memory in Alzheimer's by targeting the blood-brain barrier instead of amyloid ...

However, this trait is one of the most common signs of frontotemporal dementia (FTD) — the most common neurodegenerative ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

A new method developed by researchers at the Nuffield Department of Medicine, University of Oxford, could soon unlock the vast repository of ...